Enocitabine

Drugbox
IUPAC_name = N- [1- [(2R,3S,4S,5R)-3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl] -2-oxopyrimidin-4-yl] docosanamide

---

width = 320
CAS_number = 55726-47-1
CAS_supplemental =
ATC_prefix =
ATC_suffix =
ATC_supplemental =
PubChem = 71734
DrugBank =
chemical_formula =
C=31 | H=55 | N=3 | O=6
molecular_weight = 565.78 g/mol
smiles = CCCCCCCCCCCCCCCCCCCCCC(=O)NC1=NC(=O)N(C=C1)C2C(C(C(O2)CO)O)O
bioavailability =
protein_bound =
metabolism =
elimination_half-life =
excretion =
pregnancy_AU =
pregnancy_US =
pregnancy_category=
legal_AU =
legal_CA =
legal_UK =
legal_US =
legal_status = Rx-only
routes_of_administration = IV

Enocitabine (INN, marketed under the brand name Sunrabin) is a nucleoside analog used as chemotherapy.

It contains the emulsifier HCO-60, which can cause allergic reactions.cite journal |author=Tatetsu H, Asou N, Nakamura M, "et al" |title= [Allergic reaction against an emulsifier, HCO-60, contained in multamin and enocitabine] |language=Japanese |journal=Rinsho Ketsueki |volume=44 |issue=7 |pages=471–3 |year=2003 |month=July |pmid=12931567 |doi= |url=]

References

* [http://www.ak-hcc.com/medical/product/SBA/SBAten.pdf Sunrabin]